Evidence map›Paper›PMID 18483327›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2008

Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women.

Lori C Sakoda, Christie Blackston, Jennifer A Doherty, Roberta M Ray, Ming Gang Lin, Helge Stalsberg, Dao Li Gao, Ziding Feng, David B Thomas, Chu Chen

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. HSD17B1 genetic variants and hormone receptor-defined breast cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2008
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Cancer management and research · 2018
    Article
  7. Article
  8. Article
  9. CYP11A1 microsatellite (tttta)n polymorphism in PCOS women from South India.Journal of assisted reproduction and genetics · 2014
    Article
  10. CYP17 polymorphism (rs743572) is associated with increased risk of gallbladder cancer in tobacco users.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Lori C SakodaProgram in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Christie Blackston
Jennifer A Doherty
Roberta M Ray
Ming Gang Lin
Helge Stalsberg
Dao Li Gao
Ziding Feng
David B Thomas
Chu Chen
Faculty of Public Health · GBArizona Research Center · USCancer Research Center · USFudan University · CNUiT The Arctic University of Norway · NO

Funding

Title OmittedK05CA092002 · NCI · UNIVERSITY OF WASHINGTON · PI WEISS, NOEL S · 2002 to 2013
$1.5M
BREAST CANCER AND GENE POLYMORPHISMS IN CHINESE WOMENR01CA084141 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CHEN, CHU · 2001 to 2003
$1.4M
NCI NIH HHS CA84141-01A1NCI NIH HHS K05 CA092002NCI NIH HHS R01 CA084141
6 · The paper itself

Abstract

Common variants in genes encoding for key enzymes involved in steroidogenesis may alter sex steroid hormone levels, thereby influencing susceptibility to breast carcinoma and related conditions. In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease. We also evaluated whether these relationships differed by the presence of proliferation in the extratumoral epithelium or fibrocystic lesions, menopausal status, or body mass index. Only CYP11A1 genotype was related to breast cancer risk, with women homozygous for the 4-repeat allele, relative to those homozygous for the 6-repeat allele, at reduced risk (age-adjusted odds ratio, 0.58; 95% confidence interval, 0.37-0.91). There was some suggestion of a stronger inverse association for breast cancer with evidence of proliferation in the extratumoral epithelium than for breast cancer without extratumoral proliferation. Breast cancer risk associated with CYP11A1 genotype did not differ by menopausal status or body mass index level. No associations between CYP11A1, CYP17A1, and HSD17B1 genotypes and risk of fibrocystic breast conditions were observed. Our findings support the possibility that common allelic variation at the CYP11A1 D15S520 locus alters breast cancer risk in Chinese women.

Indexed as

Polymorphism, GeneticAdultAgedAsian PeopleBreast NeoplasmsCase-Control StudiesCholesterol Side-Chain Cleavage EnzymeEstradiol DehydrogenasesFemaleFibrocystic Breast DiseaseGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansLogistic ModelsMiddle AgedCholesterol Side-Chain Cleavage EnzymeCYP17A1 protein, humanEstradiol DehydrogenasesHSD17B1 protein, humanSteroid 17-alpha-Hydroxylase

Identifiers

PMID18483327
PMCPMC2791045
OpenAlexW2141362214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.